Tacita Capital’s Merck MRK Stock Holding History

Tacita Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-159	Closed	-$12K	–	205
2020 Q4	$12K	Buy	+159	New	+$12.2K	0.01%	178

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tacita Capital's MRK Position: Q1 2021 in Review

Tacita Capital sold out of Merck (MRK) in Q1 2021, closing a stake of 159 shares — an estimated $12K sold.

Tacita Capital first reported a position in MRK in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

Tacita Capital reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
Tacita Capital sold 159 Merck shares in Q1 2021, an estimated $12K.
Tacita Capital first reported a position in Merck in Q4 2020 and held it in 1 quarter.
Tacita Capital's Merck position peaked at $12K in Q4 2020.
2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Tacita Capital's 13F filing for Q1 2021, filed 14 May 2021.